Drupal.behaviors.print = function(context) {window.print();window.close();}>
Nuclea Biotechnologies Initiates Series C Round Targeting $10M
April 13, 2012
Nuclea Biotechnologies Initiates Series C Round Targeting $10M
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Nuclea Files for FDA Approval of Breast Cancer, Prostate Cancer Assays
January 12, 2012 / GenomeWeb Daily News
With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise
May 8, 2013 / Pharmacogenomics Reporter
Genomics in the Journals
April 4, 2013 / GenomeWeb Daily News
Nuclea Biotechnologies Raises $1.1M Toward $2.5M Financing Round
February 22, 2013 / GenomeWeb Daily News
Cepheid, OHSU Co-developing Cancer MDx Tests for GeneXpert
February 19, 2013 / GenomeWeb Daily News